GeneBioTech Co. ,Ltd (KOSDAQ:086060)
4,890.00
+15.00 (0.31%)
At close: Apr 21, 2026
GeneBioTech Co. ,Ltd Market Cap
GeneBioTech Co. ,Ltd has a market cap or net worth of 42.11 billion as of April 21, 2026. Its market cap has increased by 54.50% in one year.
Market Cap
42.11B
Enterprise Value
32.17B
Revenue
90.79B
Ranking
n/a
PE Ratio
11.11
Stock Price
4,890.00
Market Cap Chart
Since April 28, 2006, GeneBioTech Co. ,Ltd's market cap has increased from 35.91B to 42.11B, an increase of 17.25%. That is a compound annual growth rate of 0.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 41.98B | 21.57% |
| Dec 30, 2025 | 34.53B | 21.88% |
| Dec 30, 2024 | 28.33B | -24.54% |
| Dec 28, 2023 | 37.54B | 9.27% |
| Dec 29, 2022 | 34.36B | -23.85% |
| Dec 30, 2021 | 45.12B | -8.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jin Yang Pharmaceutical | 62.81B |
| Kyung Nam Pharm | 60.10B |
| Korea Arlico Pharm | 56.71B |
| RP Bio | 55.46B |
| Eagle Veterinary Technology Co.,Ltd | 50.25B |
| Korean Drug | 46.05B |
| HLscience | 42.22B |
| Seoul Pharma | 33.81B |